← Home / NOVAVAX, INC. (NVAX)
Stock Analysis
NOVAVAX, INC. (NVAX)
NVAX
NVAX · Market data
7.44 +1.36%
Track NVAX in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when NVAX price is:
52W Range Position
25%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-07-31 11:47 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and invalidation levels before acting.
⚖️
✓
Fundamentals
Weak / Negative
✓
Price Structure
Vulnerable
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
—
↗
Break Above
Confirmation improves above resistance.
8.48
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below —
Recent Company Events
SEC VERIFIED
Latest material filings
MAY
6
●
Financial Results
HIGH
Novavax Reports First Quarter 2026 Financial Results and Operational Highlights
(Nasdaq: NVAX) today announced its financial results and operational highlights for the first quarter ended March 31, 2026.
8-K Filing • SEC EDGAR
What's Driving NVAX?
📈 Technical recovery is improving
Momentum is Neutral. Watch 8.48 for confirmation and — for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
—
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Downtrend Structure
Downtrend line not broken yet · score 0
Trigger
11.35
Invalidation
11.35
RSI(14)
31.4
Price Chart
NVAX — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-30
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$1.2B
Company size
EV
$1.3B
Debt-adjusted value
P/E
2.8
Low multiple
P/S
2.1
Low sales multiple
P/B
-8.5
Not meaningful
EV/Sales
2.2
Low sales multiple
EV/EBIT
2.9
Low multiple
P/FCF
-5.0
Not meaningful
FCF Yield
-20.02%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Weak
●
Profitability
Negative
≈
Cash Flow
Recovering
⚖
Balance Sheet
Manageable
💵 Revenue
139.51M
↘ Weak
📈 Net Income
-9.49M
↘ Negative
🧮 EPS (Basic)
-0.06
↘ Negative
NOVAVAX, INC.
Related Opportunities